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INTRODUCTION
Charcot-Marie-Tooth disease (CMT) is the most common
inherited motor and sensory neuropathy, with an estimated
prevalence of 1/2,500. CMT can be divided into one of two
types: demyelinating (CMT1) or axonal (CMT2) (1). CMT1A
duplication on chromosome 17p11.2-p12 is caused by an
unequal crossover between two homologous repetitive ele-
ments that flank the 1.4-Mb region (2). Duplication is found
in approximately 70% of patients with CMT1 (3). The peri-
pheral myelin protein 22 (PMP22) gene is located within
the duplication region, and alterations in the dosage of the
PMP22 gene are the primary cause of the CMT1A pheno-
type (2). In contrast, hereditary neuropathy with liability to
pressure palsies (HNPP) is caused by deletion of the same
1.4-Mb region, and patients with HNPP deletion have only
one copy of PMP22 (4, 5). Myelin plays an important role
in saltatory impulse transmission along neuronal extensions
and communication between neurons and Schwann cells (6). 
Schwannomas are tumors that originate in the Schwann
cells of the peripheral nervous system, and the prevalence of
schwannomas is estimated at 1/40,000 births (7, 8). Bilater-
al vestibular schwannomas and ophthalmological abnormal-
ities are hallmarks of neurofibromatosis type 2 (NF2), where-
as multiple fibromas are characteristic of neurofibromatosis
type 1 (NF1) (8, 9). However, schwannomatosis character-
ized by multiple peripheral nerve and spinal schwannomas
is clinically similar to NF1 and NF2, but has a distinct genet-
ic background (9).
A patient with the rare combination of HNPP with PMP-
22 deletion and schwannomas has been previously reported
(10). However, there has been no report of CMT1A in a pati-
ent with PMP22 duplication and schwannoma. In the pre-
sent study, we present two patients in a CMT1A family (fa-
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Charcot-Marie-Tooth 1A Concurrent with Schwannomas of the Spinal
Cord and Median Nerve
We identified Charcot-Marie-Tooth disease type 1A (CMT1A) in a family with schwan-
nomas in the spinal cord and median nerve. The CMT1A in this family showed an
autosomal dominant pattern, like other CMT patients with PMP22 duplication, and
the family also indicated a possible genetic predisposition to schwannomas by ‘mo-
ther-to-son’ transmission. CMT1A is mainly caused by duplication of chromosome
17p11.2-p12 (PMP22 gene duplication). A schwannoma is a benign encapsulated
tumor originating from a Schwann cell. A case of hereditary neuropathy with liabili-
ty to pressure palsies (HNPP) concurrent with schwannoma has been previously
reported. Although it seems that the co-occurrence of CMT1A and schwannomas
in a family would be the result of independent events, we could not completely ignore
the possibility that the coincidence of two diseases might be due to a shared genet-
ic background.
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Patient 1: The proband (M/14 yr, Fig. 1: III-3) was admit-
ted to our hospital due to radiating pain in his left leg last-
ing for two months. In addition, he had walking difficulty
from 9 yr of age and had a steppage gait with foot dorsiflex-
ion weakness, pes cavus, and hammer toes. Moreover, we fo-
und a palpable soft tissue mass with tenderness on the medi-
al side of the right middle humerus. A neurological exami-
nation performed at the age of 14 yr revealed weakness of the
distal muscles of the lower limbs. Vibration and pain percep-
tions were reduced in the distal upper and lower limbs, and
stretch reflexes were decreased. Nerve conduction studies
showed marked reduction in motor and sensory nerve con-
duction velocities (NCVs) consistent with demyelinating
neuropathy. When stimulating at the elbow, right median
motor NCV was 21.1 m/sec (normal ≥50.5 m/sec), and com-
pound muscle action potential (CMAP) was 11.6 mV (nor-
mal ≥6.0 mV), and left motor NCV 19.8 m/sec, CMAP 9.1
mV. Right median sensory NCV between finger and wrist
was 18.9 m/sec (normal ≥39.3 m/sec), and sensory nerve
action potential (SNAP) was 8.9 μ V (normal ≥8.8 μ V), and
left sensory NCV 18.2 m/sec, SNAP 7.4 μ V. During stimu-
lation at the axillary level, right median motor NCV was
21.1 m/sec (normal ≥51.2 m/sec), and CMAP was 9.0 mV
(normal ≥6.0 mV), and left motor NCV 23.0 m/sec, CMAP
9.5 mV. Right sensory NCV between the elbow and axilla was
20.9 m/sec (normal ≥48.0 m/sec), and SNAP was 13.0 μ V
(normal ≥13.0 μ V), and left sensory NCV 21.6 m/sec, SNAP
4.5 μ V. Magnetic resonance imaging (MRI) scans of the tho-
racolumbar spine revealed a contrast-enhancing intradural ex-
tramedullary mass (1.8×2.4 cm) at the T12-L1 level (Fig.
2A). Surgery was performed, and the spherical mass was re-
moved. The radiating pain in his leg had completely resolved
one month after surgery. The histopathological features of
this mass included crowded spindle cells with palisading nuclei
and loosely arranged spindle cells in abundant myxomatous
matrix areas (Fig. 3). We also found another schwannoma
(1.5×2.0 cm) adjacent to the right median nerve at the level
of the middle humerus (Fig. 2B).
Patient 2: The mother of the proband (F/40 yr, Fig. 1: II-
6) complained of walking difficulty. She began to experience
weakness in both lower extremities at 20 yr of age. At 25
yr, she had numbness and pain in her right hand and under-
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Fig. 1. Pedigree of a CMT1A family (FC270) with PMP22 duplication. The filled symbols indicate affected males (  ) and females (  ) with
CMT neuropathy, and the open symbols represent unaffected males (  ) and females (  ). The arrow indicates the proband, and asterisks
indicate the available DNA samples. In the proband, schwannomas were found in the spinal cord and median nerves. His mother (II-6) also
had a schwannoma in the median nerve.
Fig. 2. MRI of the thoracolumbar spinal cord and right humerus.
(A) Sagittal T1-weighted image shows a well demarcated 1.8×2.4
cm sized contrast-enhancing intradural extramedullary mass at
the T12-L1 level. (B) Sagittal T2-weighted MR image showing a well
demarcated 1.5×2.0 cm sized ovoid shaped mass adjacent to
the median nerve on the medial side of the right middle humerus.
A Bwent surgery for carpal tunnel syndrome, which revealed the
presence of a schwannoma. The pain decreased after surgery,
and her symptoms had resolved completely three months
later. A neurologic examination performed at the age of 40
yr revealed moderate weakness and atrophy in the distal mus-
cles of the lower limbs and pes cavus in both feet. All of her
sensory modalities were impaired, and all muscle stretch re-
flexes were absent. When stimulating at the elbow, median
motor NCV was 20.0 m/sec, and CMAP was 9.5 mV, but
SNAPs were not recordable. In this FC270 family, we iden-
tified duplication of the PMP22 gene in nine family mem-
bers by genotyping six microsatellites within the 17p11.2-
p12 duplication region (11). The duplication was well coseg-
regated with familial members diagnosed with demyelinat-
ing CMT1 (Fig. 1). However, no causative mutation in the
NF1 gene was identified not only in patients with CMT1A
alone, but also in those with the both CMT1A and schwan-
noma. 
As neurofibromatosis was considered, additional ophthal-
mological and dermatological examinations and imaging stu-
dies of the brain and spinal cord were performed in the pro-
band (III-3), his sister (III-4), mother (II-6), and aunt (II-8).
These tests showed normal findings without any evidence
for NF type 1 or 2.
DISCUSSION
We present two patients in a family with an unusual com-
bination of CMT1A with PMP22 duplication and schwan-
nomas. The CMT1A duplication was found to have an auto-
somal dominant pattern of inheritance. Schwannomas were
found in the proband and his mother, which indicated a ge-
netic predisposition, acting in an autosomal dominant man-
ner.
The characteristics of NF1 are cafe au lait patches, neurofi-
bromas, Lisch nodules and bony dysplasia. The NF1 gene
was identified on chromosome 17q11.2 (8); however, no cau-
sative mutation in NF1 was found in the proband. In addi-
tion, NF2 is a rare autosomal dominant neurocutaneous dis-
ease characterized by bilateral vestibular schwannomas (9).
No further evidence for NF1 or NF2 was found in either of
our patients. Multiple schwannomas in the absence of other
NF2 stigmata are characteristic of schwannomatosis, a newly
described syndrome with genetic aberrations on chromosome
22 outside of the NF2 locus (9). 
Patient 2, who was initially diagnosed with carpal tunnel
syndrome, had complained of numbness and pain in her hand,
and we finally found a schwannoma. In addition, her son had
radiating pain from the proximal thigh to the distal foot, and
MRI and histology revealed a schwannoma. Considering the
proband’s family history, we carefully examined his entire
body and found a mass on his right arm. Imaging of the hu-
merus revealed a secondary schwannoma. Therefore, in nerve
tumors, careful examination would be helpful for the detec-
tion of causative lesions, such as schwannomas.
Hechkmann et al. reported a HNPP patient with a PMP22
deletion and schwannoma, and they suggested the possibili-
ty that dysfunction of PMP22 may not only result in periph-
eral neuropathy but also promote the development of Sch-
wann cell neoplasms (10). CMT1A and HNPP are periph-
eral neuropathies typically caused by abnormal dosages of
PMP22. Interestingly, CMT1A as well as HNPP are associ-
ated with point mutations in PMP22 gene (12, 13). Altho-
ugh it seems that the occurrence of two diseases in the same
patient (CMT1A or HNPP vs. schwannoma) might be mere-
ly coincidental, we could not completely ignore the possibil-
ity that the coincidence of two diseases might be due to a sha-
red genetic background. Therefore, although further studies
are needed to determine the association between schwanno-
mas and the PMP22 gene, a common pathogenetic basis for
the disturbance of the Schwann cell life cycle may be involved.
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